Close Menu

In PLoS One this week, investigators at McGill University report their use of exon-level transcriptome profiling in murine breast cancer, which revealed "splicing changes specific to tumors with different metastatic abilities." Specifically, in their statistical analysis the team found "significant expression changes in four percent of exons and one percent of intronic regions, affecting 2,263 out of 16,654 genes.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

23andMe has launched a new tool that estimates someone's risk of developing severe COVID-19 if infected, Bloomberg reports.

The Guardian reports that Pasteur Institute researchers are halting their development of a SARS-CoV-2 vaccine following disappointing initial results.

The Wall Street Journal reports that an increased number of younger patients have been hospitalized as the new SARS-CoV-2 strain spread across the UK.

In Cell this week: proteomic patterns among COVID-19 affected tissue samples, transcriptome atlas of developing intestines, and more.